Risk Assessment and Management Program (RAMP) on Knee Osteoarthritis in Primary Care - Trial NCT06283147
Access comprehensive clinical trial information for NCT06283147 through Pure Global AI's free database. This phase not specified trial is sponsored by Chinese University of Hong Kong and is currently Recruiting. The study focuses on Knee Osteoarthritis. Target enrollment is 228 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Risk assessment and Management Programme - Knee Osteoarthritis
Interventional
behavioral
Sponsor & Location
Chinese University of Hong Kong
Timeline & Enrollment
N/A
Apr 01, 2024
Apr 01, 2026
Primary Outcome
Knee pain
Summary
The goal of this clinical trial is to determine the clinical effectiveness of a Chronic Care
 Model (CCM) named Risk Assessment and Management Program on Knee OA (RAMP-Knee OA) in adults
 with knee Osteoarthritis (Knee OA) at 52 weeks.
 
 Participants will be screened for eligibility to participate. After confirming eligibility,
 participants will complete the baseline assessment and be randomized into one of the
 following groups (n=114 for each group):
 
 1. RAMP Knee-OA group
 
 2. Usual care group
 
 Outcomes will be measured at baseline, week 16, week 32, and week 52.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06283147
Non-Device Trial